Drug intelligence / Profile preview

NeoFitoroid

Development stage
Unknown
Lead developer
Aboca
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical, Rectal
01

Overview

NeoFitoroid is a plant-based medical device developed by Aboca for the treatment of hemorrhoidal disease (internal and external) and associated symptoms such as pain, burning, and pruritus. It functions by creating a protective, mucoadhesive barrier on the anal and perianal mucosa, which shields the tissue from contact with irritants and reduces friction during bowel movements. The formulation contains a synergistic complex of plant extracts, including Helydol (a lipophilic fraction of Helichrysum flowering tops), Ruscus root, Aloe vera leaf gel, and essential oils. These ingredients provide soothing and antioxidant properties to support the physiological healing process without the use of corticosteroids or local anesthetics. It is typically administered topically or rectally as an ointment.

Brand names
NeoFitoroid
Other names
NeoFitoroid bioPomataFitoroid

Beyond the preview

Go deeper on NeoFitoroid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NeoFitoroid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call